Dr Peter McCormick
William Harvey Research Institute
School of Medicine & Dentistry, Queen Mary University of London
p.mccormick@qmul.ac.ukSchool of Medicine & Dentistry, Queen Mary University of London
https://www.qmul.ac.uk/whri/people/academic-staff/items...
Research Interests
We use induced pluripotent stem cells in 2D and 3D cultures to look for early molecular signatures and mechanisms of disease onset in degenerative diseases. We also use 3D cultures of tumour cell lines to identify novel targets of metastasis and tumour growth.
Current Funded Predictive in vitro Model Research
| An in silico structure-based approach to map the druggable allosteric space of membrane receptors | Principal Investigator: Peter McCormick BBSRC Biotechnology and Biological Sciences Research Council (£224,374) 04-11-2019 - 03-11-2021 |
| Systems Analysis of Key Nodes in Neurodegenerative Diseases | Principal Investigator: Peter McCormick MRC Medical Research Council (£334,170) 03-04-2018 - 31-12-2021 |
| Using a pathway dynamics approach to identify novel EP4 receptor agonists for the treatment of cardiac inflammation and fibrosis (iCASE matching) | Principal Investigator: Peter McCormick Co-investigator: Tom Nightingale Barts and the London Charity (£107,727) 01-10-2019 - 30-09-2023 |